CASE: We report a 32-year old relapse case of Visceral leishmaniasis, treated with Paromomycin who belonged from a endemic zone of Bihar state, India. After confirmation, he was treated with Amphotericin B, followed by Liposomal Amphotericin B in full course and even in higher dose. But after each therapy, the patient either did not responded or relapsed after treatment. Ultimately, the patient was successfully treated with combination therapy of Liposomal amphotericin B and Miltefosine without any relapse. CONCLUSION: The multi-drug unresponsive Visceral leishmaniasis cases could pose a major threat to treatment strategy in the elimination program. In such situation, combination therapy seems to be a better approach that needs to be explored.
CASE: We report a 32-year old relapse case of Visceral leishmaniasis, treated with Paromomycin who belonged from a endemic zone of Bihar state, India. After confirmation, he was treated with Amphotericin B, followed by Liposomal Amphotericin B in full course and even in higher dose. But after each therapy, the patient either did not responded or relapsed after treatment. Ultimately, the patient was successfully treated with combination therapy of Liposomal amphotericin B and Miltefosine without any relapse. CONCLUSION: The multi-drug unresponsive Visceral leishmaniasis cases could pose a major threat to treatment strategy in the elimination program. In such situation, combination therapy seems to be a better approach that needs to be explored.
Authors: S Sundar; D K More; M K Singh; V P Singh; S Sharma; A Makharia; P C Kumar; H W Murray Journal: Clin Infect Dis Date: 2000-10 Impact factor: 9.079
Authors: R Badaro; T C Jones; E M Carvalho; D Sampaio; S G Reed; A Barral; R Teixeira; W D Johnson Journal: J Infect Dis Date: 1986-12 Impact factor: 5.226
Authors: Shyam Sundar; T K Jha; Chandreshwar P Thakur; Prabhat K Sinha; Sujit K Bhattacharya Journal: N Engl J Med Date: 2007-06-21 Impact factor: 91.245
Authors: Karin Seifert; F Javier Pérez-Victoria; Marianne Stettler; María P Sánchez-Cañete; Santiago Castanys; Francisco Gamarro; Simon L Croft Journal: Int J Antimicrob Agents Date: 2007-07-12 Impact factor: 5.283
Authors: Avelar Alves de Silva; Álvaro Pacheco e Silva Filho; Ricardio de Castro Cinta Sesso; Ronaldo de Matos Esmeraldo; Cláudia Maria Costa de Oliveira; Paula Frassinetti Fernandes; Rodrigo Alves de Oliveira; Leila Silveira Veira de Silva; Valencio Pereira de Carvalho; Carlos Henrique Nery Costa; Jesusmar Ximenes Andrade; Diana Marisa Barros da Silva; Roosevelt Valente Chaves Journal: BMC Infect Dis Date: 2015-02-25 Impact factor: 3.090